The effectiveness of dapagliflozin and lixisenatide in managing Type 2 diabetes: a real-world observational study

被引：0
|
作者：
Duffy, A. [1 ]
Smith, C. [1 ]
Harrow, C. [1 ]
McGowan, N. [1 ]
McIntyre, M. [1 ]
So, B. [1 ]
Jones, C. [2 ]
Gonzalez, N. [1 ]
机构：
[1] Royal Alexandra Hosp, Dept Endocrinol, Paisley, Renfrew, Scotland
[2] Inverclyde Royal Hosp, Dept Endocrinol, Greenock, Scotland
来源：
DIABETIC MEDICINE | 2016年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P437
引用
收藏
页码：166 / 166
页数：1
相关论文
共 50 条
  • [41] Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study
    Kick, Anastas
    M'Rabet-Bensalah, Khadija
    Acquistapace, Flavio
    Amadid, Hanan
    Ambuhl, Robert A.
    Braae, Uffe Christian
    Item, Flurin
    Schultes, Bernd
    Zuger, Thomas
    Rudofsky, Gottfried
    DIABETES THERAPY, 2024, 15 (03) : 623 - 637
  • [42] Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study
    van Houtum, William
    Schrombges, Patrick
    Amadid, Hanan
    van Bon, Arianne C.
    Braae, Uffe C.
    Hoogstraten, Charlotte
    Herrings, Hans
    DIABETES THERAPY, 2024, 15 (08) : 1749 - 1768
  • [43] Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety
    Ponzani, Paola
    Berra, Cesare
    Di Lelio, Alessandra
    Del Sindaco, Paola
    Di Loreto, Chiara
    Reggiani, Francesco
    Lucisano, Giuseppe
    Rossi, Maria Chiara
    DIABETES THERAPY, 2018, 9 (06) : 2209 - 2218
  • [44] Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
    Susan Robinson
    Kristina S. Boye
    Reema Mody
    Alena Antonie Strizek
    Manige Konig
    Raleigh E. Malik
    Tessa Kennedy-Martin
    Diabetes Therapy, 2020, 11 : 1437 - 1466
  • [45] Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study
    Anastas Kick
    Khadija M’Rabet-Bensalah
    Flavio Acquistapace
    Hanan Amadid
    Robert A. Ambühl
    Uffe Christian Braae
    Flurin Item
    Bernd Schultes
    Thomas Züger
    Gottfried Rudofsky
    Diabetes Therapy, 2024, 15 : 623 - 637
  • [46] Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
    Robinson, Susan
    Boye, Kristina S.
    Mody, Reema
    Strizek, Alena Antonie
    Konig, Manige
    Malik, Raleigh E.
    Kennedy-Martin, Tessa
    DIABETES THERAPY, 2020, 11 (07) : 1437 - 1466
  • [47] Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety
    Paola Ponzani
    Cesare Berra
    Alessandra Di Lelio
    Paola Del Sindaco
    Chiara Di Loreto
    Francesco Reggiani
    Giuseppe Lucisano
    Maria Chiara Rossi
    Diabetes Therapy, 2018, 9 : 2209 - 2218
  • [48] Effect of Dapagliflozin in Combination with Lobeglitazone and Metformin in Korean Patients with Type 2 Diabetes in Real-World Clinical Practice
    Seo, Da Hea
    Suh, Young Ju
    Cho, Yongin
    Ahn, Seong Hee
    Seo, Seongha
    Hong, Seongbin
    Lee, Yong-Ho
    Choi, Young Ju
    Lee, Eunjig
    Kim, So Hun
    YONSEI MEDICAL JOURNAL, 2022, 63 (09) : 825 - 833
  • [49] Efficacy of Dapagliflozin in Southern Europe Across the Spectrum of Characteristics of Type 2 Diabetes: An International Real-World Analysis
    Fadini, Gian Paolo
    Morales, Cristobal
    Caballero, Irene
    Gonzalez, Beatriz
    Tentolouris, Nikolaos
    Consoli, Agostino
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 3533 - 3541
  • [50] A real-world analysis of glycemic control among patients with type 2 diabetes treated with canagliflozin versus dapagliflozin
    Blonde, Lawrence
    Patel, Charmi
    Bookhart, Brahim
    Pfeifer, Michael
    Chen, Yen-Wen
    Wu, Bingcao
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (06) : 1143 - 1152
12345